Publications by authors named "Nobuaki Mori"

() is known to cause intra-abdominal and anaerobic bloodstream infections. However, clinical insights and information on antimicrobial susceptibility in infections are limited. This study aimed to elucidate the clinical characteristics and antimicrobial susceptibility of infections.

View Article and Find Full Text PDF

Thrombocytopenia derived from tedizolid (TZD) has been reported but less frequently than that from linezolid. Only a few reports have investigated the relationship between the efficacy and safety of TZD administration. This study aimed to measure TZD concentration and investigate the relationship between efficacy and safety.

View Article and Find Full Text PDF

Background:  () bloodstream infection (SAB) remains a major clinical challenge despite appropriate antimicrobial therapy. Recent studies have suggested the potential benefits of P2Y12 inhibitors in SAB treatment, but controversy persists regarding their optimal use. Moreover, the effects of P2Y12 inhibitors in Japanese patients remain unclear.

View Article and Find Full Text PDF

The present study aimed to evaluate the impact of prospective audit and feedback (PAF) on the use of inpatient broad-spectrum antibiotics for more than 10 days using days of therapy (DOT) and a novel metric called days of antibiotic spectrum coverage (DASC) to assess whether the antimicrobial spectrum was narrowed. Conducted at Aichi Medical University Hospital in Japan, the study compared a six-month baseline period (April to September 2022) with a six-month intervention period (April to September 2023). The primary outcome measures were changes in DOT/patient and DASC/patient for broad-spectrum antibiotics.

View Article and Find Full Text PDF

A previous study reported that the incidence of hyponatremia after linezolid (LZD) use was higher than that with vancomycin (VCM) use in adults. However, hyponatremia due to LZD in neonates and infants was not investigated. This study aimed to compare the incidence of hyponatremia between LZD and VCM use in neonates and infants.

View Article and Find Full Text PDF

Introduction: While respiratory syncytial virus (RSV) is one of the most common pathogens in adults admitted to the ICU due to respiratory diseases, no reports regarding the occurrence rate of RSV infections in adults in Japan during the COVID-19 pandemic exist.

Patients And Methods: We conducted this retrospective study to examine the exact occurrence rate of RSV infections in adults. We reviewed all patients (≥18 years) with any respiratory symptoms who received quantitative polymerase chain reaction (PCR) using nasopharyngeal samples for respiratory viruses by GeneLEAD at the Aichi Medical University Hospital between November 2022 and November 2023.

View Article and Find Full Text PDF

Background: Since the appropriate antibiotic duration for uncomplicated Staphylococcus aureus (S. aureus) bacteremia (u-SAB) in an immunocompromised state is still unclear, physicians are likely to extend antibiotic therapy from 2 weeks to 4-6 weeks. To examine the appropriate duration of antibiotic therapy for u-SAB, we performed this study.

View Article and Find Full Text PDF

Endometritis occurs frequently in humans and animals, which can negatively affect fertility and cause preterm parturition syndrome. Orally administered , a butyrate-producing gram-positive anaerobe, exhibits anti-inflammatory effects. However, the precise mechanism by which attenuates endometritis remains unclear.

View Article and Find Full Text PDF

Despite advances in medical technology, lung cancer still has one of the highest mortality rates among all malignancies. Therefore, efforts must be made to understand the precise mechanisms underlying lung cancer development. In this study, we conducted lung and gut microbiome analyses and a comprehensive lipid metabolome analysis of host tissues to assess their correlation.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on patients infected with Fusobacterium spp. in a Japanese hospital from 2014 to 2023, revealing a median patient age of 61 years and a significant proportion of community-acquired infections (84.6%).
  • About 25% of patients had solid organ malignancies, with an associated 30-day mortality rate of only 1.3%.
  • Resistance to antibiotics like penicillin and moxifloxacin was found, emphasizing the need for careful clinical management of Fusobacterium infections.
View Article and Find Full Text PDF
Article Synopsis
  • Tetanus incidence has dropped in developed countries due to vaccination, but it remains a risk worldwide, especially in adults with decreasing antibody levels; canine bites can potentially lead to infection.
  • A 46-year-old unvaccinated Japanese man developed tetanus symptoms 19 days after a dog bite, requiring hospitalization, despite receiving appropriate medical treatment.
  • This case emphasizes the importance of tetanus vaccination for adults, especially those at risk, as only a few cases of tetanus from dog bites have been documented, underscoring the need for ongoing education about immunization.
View Article and Find Full Text PDF
Article Synopsis
  • A rare case of an intra-abdominal abscess and bacteremia due to a specific pathogen was reported in a 75-year-old man following total gastrectomy for gastric cancer.
  • The patient developed symptoms 17 days post-surgery, leading to the diagnosis confirmed by imaging and culture results.
  • This case underscores the need for awareness among healthcare professionals about this pathogen as a possible cause of atypical post-surgical infections, alongside typical pathogens like Enterobacteriaceae, and suggests further research is needed on this topic.
View Article and Find Full Text PDF

Background: Current models for predicting Clostridioides difficile infection (CDI) recurrence rates have a limited capacity to account for important risk factors. This study developed a clinical prediction rule for CDI recurrence.

Methods: This retrospective cohort study evaluated 209 patients with CDI at a university hospital in Japan.

View Article and Find Full Text PDF

The coronavirus disease (COVID-19) pandemic continues to threaten global public health. Remdesivir and monoclonal antibodies have shown promise for COVID-19 treatment of patients who are immunocompromised, including those with cancer, transplant recipients, and those with autoimmune disorder. However, the effectiveness and safety of this combination therapy for patients who are immunosuppressed remain unclear.

View Article and Find Full Text PDF

Introduction: Infection and mortality rates caused by the coronavirus infectious disease 2019 (COVID-19) pandemic were high. However, the influence of the COVID-19 pandemic on the clinical burden in medical facilities remains to be clarified in Japan.

Materials And Methods: This study used a questionnaire-based web survey to clarify how the COVID-19 pandemic affected infectious disease practice and infection control.

View Article and Find Full Text PDF

Background infection (CDI) recurrence is a public health concern as well as a health economic burden. Bezlotoxumab treatment is one way to prevent recurrence; however, its clinical results have not been reported in Japan. Therefore, we investigated the efficacy and safety of bezlotoxumab in patients with CDI at a university hospital in Japan and compared them with previously reported findings.

View Article and Find Full Text PDF

The human body is host to a large number of commensal microbial species such as bacteria, fungi, and viruses. Among these, the human mycobiome is often neglected as a potential cause of disease, as it is thought to be comparatively much less abundant and less diverse than the human bacteriome. Additionally, most fungi are not easily cultured, even in specific media.

View Article and Find Full Text PDF
Article Synopsis
  • The study compares the effectiveness of two treatments for Clostridioides difficile infection (CDI): fidaxomicin (FDX) and oral metronidazole (MNZ), analyzing data from patients treated between January 2015 and March 2023.
  • In terms of global cure rates, FDX had a higher rate (70%) compared to MNZ (53.3%), but this difference was not statistically significant.
  • The study highlights that while FDX shows better clinical cure and lower recurrence rates, MNZ leads to a notable rate of treatment changes due to initial failures (18.7%), indicating potential issues with MNZ effectiveness.
View Article and Find Full Text PDF

Background: Isavuconazole is a novel triazole antifungal agent. However, the previous outcomes were highlighted by statistical heterogeneity. This meta-analysis aimed to validate the efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections (IFIs) compared with other antifungal agents (amphotericin B, voriconazole and posaconazole).

View Article and Find Full Text PDF

Objectives: Clostridioides difficile infection (CDI) is a leading cause of antimicrobial-associated colitis and is a global clinical concern. Probiotics are considered a CDI-preventive measure; however, highly inconsistent data have been previously reported. Thus, we evaluated the CDI-preventive effect of prescribed probiotics in high-risk older patients receiving antibiotics.

View Article and Find Full Text PDF

Background: Proteus spp. are widespread in the environment and comprise a part of the normal flora of the human gastrointestinal tract. Only six species in this genus, including Proteus mirabilis, Proteus vulgaris, Proteus terrae, Proteus penneri, Proteus hauseri, and Proteus faecis, have been isolated from human clinical specimens.

View Article and Find Full Text PDF

Background: Recombinant human soluble thrombomodulin (rhTM) is used to treat sepsis-induced disseminated intravascular coagulation (DIC). However, no consistent clinical guidelines exist regarding the administration of rhTM in patients with sepsis-induced DIC. Therefore, we conducted this meta-analysis to evaluate the efficacy and safety of rhTM therapy in patients with sepsis-induced DIC.

View Article and Find Full Text PDF
Article Synopsis
  • - A 2-month-old girl experienced bacteremia from a rare pathogen after showing symptoms like diarrhea, poor oral intake, and vomiting; she was initially diagnosed with acute enterocolitis.
  • - Blood cultures identified Gram-negative cocci, later confirmed as a specific strain through advanced genetic analysis methods, which was challenging with standard tests.
  • - The infant was treated successfully with cefotaxime and diagnosed later with a non-IgE-mediated gastrointestinal food allergy, highlighting the need for detailed studies to understand the pathogenicity of this rare pathogen in humans.
View Article and Find Full Text PDF
Article Synopsis
  • A study analyzed the rates and impact of respiratory bacterial infections in Japanese patients hospitalized with COVID-19, finding that 7.5% of patients experienced such infections.
  • The most common causes of these infections included Staphylococcus aureus, Klebsiella pneumoniae, and Streptococcus pneumoniae, with more severe outcomes linked to hospital-acquired infections and pre-existing health conditions.
  • The research highlights the importance of monitoring and assessing bacterial complications in COVID-19 patients, as these infections can significantly increase mortality rates.
View Article and Find Full Text PDF